Approved treatments
for hypoparathyroidism

Yorvipath

Yorvipath (palopegteriparatide) is an approved daily hormone replacement therapy for the management of blood calcium levels in adults with hypoparathyroidism. It is given once a day by subcutaneous (under-the-skin) injection.

Learn more